Simple Letter Agreement Nih

A Material Transfer Agreement (MTA) is a contract that governs the transfer of research material between two organizations when the recipient intends to use it for research purposes. The MTA defines the rights of the supplier as well as the rights and obligations of the consignee with regard to the materials and any descendants, derivatives or modifications. Biological materials such as reagents, cell lines, plasmids, and vectors are the most frequently transferred materials, but ATMs can also be used for other types of materials such as chemical compounds, mouse models, and even some types of software. Based on the knowledge gained, AUTM has developed a toolkit to promote the use of standard agreements. In 1995, the NIH published the first and only widely accepted model agreements for the transfer of materials, the NIH Simple Letter Agreement for the Transfer of Materials (SLA) and the Uniform Biological Material Transfer Agreement (UBMTA), as well as guidelines for the transfer of research tools. The NIH has asked fellows to ensure that unique research resources from NIH-funded research are made available to the scientific community, either without formal agreement or under conditions or agreements that are no more restrictive for most materials than ALS. a renewed call by the NRC. For simple transfers that do not involve intellectual property, the NIH recommends a simple letter agreement. . . .